Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Stacey, Simon NManolescu, Andrei
Sulem, Patrick
Rafnar, Thorunn
Gudmundsson, Julius
Gudjonsson, Sigurjon A
Masson, Gisli
Jakobsdottir, Margret
Thorlacius, Steinunn
Helgason, Agnar
Aben, Katja K
Strobbe, Luc J
Albers-Akkers, Marjo T
Swinkels, Dorine W
Henderson, Brian E
Kolonel, Laurence N
Le Marchand, Loic
Millastre, Esther
Andres, Raquel
Godino, Javier
Garcia-Prats, Maria Dolores
Polo, Eduardo
Tres, Alejandro
Mouy, Magali
Saemundsdottir, Jona
Backman, Valgerdur M
Gudmundsson, Larus
Kristjansson, Kristleifur
Bergthorsson, Jon T
Kostic, Jelena
Frigge, Michael L
Geller, Frank
Gudbjartsson, Daniel
Sigurdsson, Helgi
Jonsdottir, Thora
Hrafnkelsson, Jon
Johannsson, Jakob
Sveinsson, Thorarinn
Myrdal, Gardar
Grimsson, Hlynur Niels
Jonsson, Thorvaldur
von Holst, Susanna
Werelius, Barbro
Margolin, Sara
Lindblom, Annika
Mayordomo, Jose I
Haiman, Christopher A
Kiemeney, Lambertus A
Johannsson, Oskar Th
Gulcher, Jeffrey R
Thorsteinsdottir, Unnur
Kong, Augustine
Stefansson, Kari
Issue Date
2007-07-01
Metadata
Show full item recordCitation
Nat. Genet. 2007, 39(7):865-9Abstract
Familial clustering studies indicate that breast cancer risk has a substantial genetic component. To identify new breast cancer risk variants, we genotyped approximately 300,000 SNPs in 1,600 Icelandic individuals with breast cancer and 11,563 controls using the Illumina Hap300 platform. We then tested selected SNPs in five replication sample sets. Overall, we studied 4,554 affected individuals and 17,577 controls. Two SNPs consistently associated with breast cancer: approximately 25% of individuals of European descent are homozygous for allele A of rs13387042 on chromosome 2q35 and have an estimated 1.44-fold greater risk than noncarriers, and for allele T of rs3803662 on 16q12, about 7% are homozygous and have a 1.64-fold greater risk. Risk from both alleles was confined to estrogen receptor-positive tumors. At present, no genes have been identified in the linkage disequilibrium block containing rs13387042. rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associated protein whose expression is implicated in breast cancer metastasis to bone.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://dx.doi.org/10.1038/ng2064ae974a485f413a2113503eed53cd6c53
10.1038/ng2064
Scopus Count
Collections
Related articles
- Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men.
- Authors: Orr N, Cooke R, Jones M, Fletcher O, Dudbridge F, Chilcott-Burns S, Tomczyk K, Broderick P, Houlston R, Ashworth A, Swerdlow A
- Issue date: 2011 Sep
- Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
- Authors: Shan J, Mahfoudh W, Dsouza SP, Hassen E, Bouaouina N, Abdelhak S, Benhadjayed A, Memmi H, Mathew RA, Aigha II, Gabbouj S, Remadi Y, Chouchane L
- Issue date: 2012 Oct
- Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.
- Authors: Elematore I, Gonzalez-Hormazabal P, Reyes JM, Blanco R, Bravo T, Peralta O, Gomez F, Waugh E, Margarit S, Ibañez G, Romero C, Pakomio J, Roizen G, Di Capua GA, Jara L
- Issue date: 2014 Jun
- Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
- Authors: Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer., Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, Ozcelik H, Glendon G, OCGN., Gerdes AM, Thomassen M, Sunde L, Caligo MA, Laitman Y, Kontorovich T, Cohen S, Kaufman B, Dagan E, Baruch RG, Friedman E, Harbst K, Barbany-Bustinza G, Rantala J, Ehrencrona H, Karlsson P, Domchek SM, Nathanson KL, Osorio A, Blanco I, Lasa A, Benítez J, Hamann U, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE, HEBON., Peock S, Cook M, Frost D, Oliver C, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Cole T, Hodgson S, EMBRACE., Godwin AK, Stoppa-Lyonnet D, Buecher B, Léoné M, Bressac-de Paillerets B, Remenieras A, Caron O, Lenoir GM, Sevenet N, Longy M, Ferrer SF, Prieur F, GEMO., Goldgar D, Miron A, John EM, Buys SS, Daly MB, Hopper JL, Terry MB, Yassin Y, Breast Cancer Family Registry., Singer C, Gschwantler-Kaulich D, Staudigl C, Hansen Tv, Barkardottir RB, Kirchhoff T, Pal P, Kosarin K, Offit K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Suttner C, Schönbuchner I, Gadzicki D, Caldes T, de la Hoya M, Pooley KA, Easton DF, Chenevix-Trench G, CIMBA.
- Issue date: 2009 Nov 15
- Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
- Authors: Huang T, Hong J, Lin W, Yang Q, Ni K, Wu Q, Sun J
- Issue date: 2013